Traders assign a 77% implied probability against the CDC issuing a Level 4 travel warning by year-end because current epidemiological surveillance shows no ongoing outbreaks or transmission patterns meeting the criteria for the highest alert level. Level 4 advisories apply to severe, widespread health risks involving limited treatment options and high potential for rapid spread. Official monitoring indicates stable case trends without novel pathogens or surges that would prompt escalation from lower advisory tiers. The market consensus reflects the lack of recent data shifts supporting such a designation, though evolving surveillance reports or unexpected clusters could introduce uncertainty before December 31.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 4 d'ici le 31 décembre ?
Oui
$71,848 Vol.
$71,848 Vol.
Oui
$71,848 Vol.
$71,848 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Traders assign a 77% implied probability against the CDC issuing a Level 4 travel warning by year-end because current epidemiological surveillance shows no ongoing outbreaks or transmission patterns meeting the criteria for the highest alert level. Level 4 advisories apply to severe, widespread health risks involving limited treatment options and high potential for rapid spread. Official monitoring indicates stable case trends without novel pathogens or surges that would prompt escalation from lower advisory tiers. The market consensus reflects the lack of recent data shifts supporting such a designation, though evolving surveillance reports or unexpected clusters could introduce uncertainty before December 31.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes